Comparison of Tuohy Needle and Quincke Needle During S1 Transforaminal Epidural Injection

Comparison of the Incidence of Intravascular Injection Using the Tuohy and Quincke Needles During Ultrasound-guided S1 Transforaminal Epidural Injection: a Prospective Randomized Controlled Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05925439

Enrollment

284

Registered

2023-06-29

Start date

2023-06-30

Completion date

2025-06-22

Last updated

2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S1 Transforaminal Epidural Block

Brief summary

Recently, Park et al. introduced a new technique for performing S1 TFESI using ultrasound. S1 TFESI using ultrasound can be considered to overcome the disadvantages of exposure to radiation. We hypothesized that the frequency of intravascular injection differs depending on the type of needle during S1 TFESI under ultrasound guidance.

Interventions

DEVICETuohy needle group

Ultrasound-guided S1 transforaminal epidural block with Touhy needle

DEVICEQuincke needle group

Ultrasound-guided S1 transforaminal epidural block with Quincke needle

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Masking description

Double

Intervention model description

Parallel assignment

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* 1\. Patient diagnosed with S1 radiculopathy because S1 root compression was confirmed on MRI and related symptoms 2. NRS of back and/or radiating pain score of 4 or more 3. Patients aged 19 years or older

Exclusion criteria

* 1\. Cases in which lumbar count is expected to be difficult due to lumbarization, sacralization, or lumbosacral transition 2. When the S1 posterior foramen is not clearly identified on ultrasound 3. Malignancy 4. Systemic infections 5. Bleeding tendency 6. Contrast allergy 7. Pregnant Women 8. If you cannot read or agree to the consent form 9. If you are unable to sign the consent form yourself

Design outcomes

Primary

Measure	Time frame	Description
incidence of intravascular injection	1 minute after finishing the procedure	incidence of intravascular injection during S1 transforaminal epidural block

Secondary

Measure	Time frame	Description
time required to complete S1 transforaminal epidural block	Baseline, 1 second after the completion of the procedure	time required to complete S1 transforaminal epidural block

Countries

South Korea

Contacts

Primary ContactDo-Hyeong Kim

breadfans@yuhs.ac0220196691

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026